Pretreatment plasma fibrinogen and serum albumin levels predict therapeutic efficacy of concurrent radiochemotherapy for esophageal squamous cell cancer

Pretreatment plasma fibrinogen and serum albumin levels predict therapeutic efficacy of concurrent radiochemotherapy for esophageal squamous cell cancer

PurposeEvidence implies that plasma fibrinogen and serum albumin level (FA score) based on plasma fibrinogen and serum albumin is related to cancer prognosis. However, the association between the FA score and therapeutic efficacy of concurrent radiochemotherapy in esophageal squamous cell carcinoma...

Full description

Bibliographic Details
Main Authors: Jijin Wang, Di Huang, Yuanyuan Wang, Qianqian Yuan, Xue Chen, Yufeng Cheng
Format: Article
Language:English
Published: Frontiers Media S.A. 2022-10-01
Series:Frontiers in Oncology
Subjects:
FA score
esophageal squamous cell carcinoma (ESCC)
therapeutic efficacy
survival
concurrent radiochemotherapy
Online Access:https://www.frontiersin.org/articles/10.3389/fonc.2022.1021214/full

Internet

https://www.frontiersin.org/articles/10.3389/fonc.2022.1021214/full

Similar Items